Desiree Granados Quick Summary: GLP-1 medications may reduce obstructive sleep apnea severity indirectly by promoting significant weight loss and improving metabolic health, which can decrease upper airway obstruction and inflammation
D-allulose 3-epimerase for low-calorie D-allulose synthesis: microbial production, characterization, and applications
GLP-1 medications are rightly celebrated for their effects on blood sugar and weight
Hoping it picks back up soon cause this is getting expensive Michelle A., 36, Halifax NS Neither concern is valid
Notably, a 2020 clinical trial involving patients with nonalcoholic steatohepatitis (NASH) revealed a 15% incidence of tumors (benign, malignant, or unspecified) (35/239) among those administered semaglutide, compared to 8% (6/80) in the control group [108]
Studies suggest that GLP-1RAs reduce inflammation by modulating immune cell activity, increasing anti-inflammatory cytokine production, shifting macrophage polarization toward an anti-inflammatory phenotype, and enhancing regulatory T-cell function to maintain immune homeostasis
